Answers are grounded in this paper and cite their sources.
A novel pharmaceutical cocrystal composed of nicotinamide (NA) and pentadecanoic acid (PDA) was synthesized and comprehensively characterized through an experimental and computational approach. Single-crystal X-ray diffraction revealed that NA–PDA crystallizes in the triclinic symmetry ( P 1 ¯ ) with two formula units per unit cell ( Z = 2). The structure is stabilized by a hydrogen bonding lattice involving N–H···O and O–H∙∙∙O interactions between the carboxamide group of NA and the carboxylic acid group of PDA. Hirshfeld surface analysis quantified the intermolecular contacts, revealing that H···H interactions dominate with 73.7% contribution, followed by H∙∙∙O/O∙∙∙H (14.3%) and C∙∙∙H/H∙∙∙C (5.6%) contacts, reflecting the balanced hydrophilic-hydrophobic character of the cocrystal. Crystal void analysis demonstrated a void percentage of 10.91%, with asphericity (0.913) and globularity (0.233) indices indicating anisotropic void geometry typical of layered structures containing long aliphatic chains. Energy‑framework calculations showed that the cocrystal is stabilized by electrostatic hydrogen bonding on the NA component and dispersive chain packing on the PDA component. Vibrational spectroscopy combined with periodic density functional theory (DFT) calculations provided detailed assignment of normal modes. The experimental infrared and Raman spectra showed excellent correlation with DFT-calculated vibrational frequencies. Powder X‑ray diffraction combined and Rietveld refinement confirmed the phase purity of the bulk material, and thermal analysis revealed melting at 84 °C followed by a single decomposition step above 170 °C. Antibacterial assays revealed that NA–PDA exhibits enhanced activity against both Gram-positive ( S. aureus, S. pneumoniae ) and Gram-negative ( E. coli, K. pneumoniae ) bacteria compared to pure components, with preferential efficacy toward Gram-positive strains. In silico ADME predictions indicated favorable pharmacokinetic properties including high gastrointestinal absorption and appropriate lipophilicity. These results demonstrate that the NA–PDA cocrystal represents a promising pharmaceutical material with favorable physicochemical profile and preliminary antibacterial activity arising from supramolecular assembly.
No takes yet. Share an insight, caveat, or question.
Neto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: